ArticleTransplantation direct2025
Combined Body Mass Index and Body Surface Area to Predict Post Kidney Transplant Outcomes in Patients With Obesity.
Article in Transplantation direct, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: The prevalence of obesity is increasing in both the general and kidney failure populations. Severe obesity (body mass index [BMI] ≥ 40 kg/m Methods: We examined post-KT adverse outcomes associated with obesity defined using combined BMI-BSA parameters in a cohort of adult KT recipients (living/deceased donor) across the United States (Scientific Registry of Transplant Recipients: 2000-2017). Recipient obesity was defined as BMI ≥30 kg/m Results: The final study included 242 432 patients; 77 556 (32.0%) had obesity based on BMI and 67 312 (28.6%) had obesity based on BSA. Compared to patients with a nonobese BMI and BSA, the adjusted risk of death-censored graft loss, all-cause graft loss, and delayed graft function was greatest when both BMI and BSA indicated obesity (adjusted hazard ratio 1.23, 95% confidence interval [CI]: 1.20-1.27, adjusted hazard ratio 1.09, 95% CI: 1.07-1.11, adjusted odds ratio 1.58, 95% CI: 1.53-1.63, respectively); a significantly greater risk than when BMI and BSA were discordant. Conclusions: Currently only BMI is considered when evaluating obesity-related KT risk; however, combined BMI-BSA obesity may better identify individuals at high risk of poor outcomes posttransplant than BMI alone.
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.